QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
Free Trial

PMV Pharmaceuticals (PMVP) SEC Filings & 10K Form

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free pmvp Stock Alerts
$1.60
-0.02 (-1.23%)
(As of 12:52 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Recent PMV Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/09/2024
12:17 PM		JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
02/29/2024
3:05 PM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:05 PM		PMV Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM		ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
02/14/2024
8:18 AM		Avoro Capital Advisors LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
6:52 AM		PMV Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
01/29/2024
2:26 PM		PMV Pharmaceuticals (Subject)
Form SC 13G/A
01/24/2024
8:01 AM		PMV Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/23/2024
8:07 AM		PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
8:40 AM		JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
3:02 PM		Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:04 PM		Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:06 PM		Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:18 PM		Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/24/2023
3:38 PM		ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
7:00 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
7:00 AM		PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/12/2023
4:02 PM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:22 PM		Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:26 PM		Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
7:01 AM		PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/07/2023
3:35 PM		BlackRock Inc. (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
06/12/2023
4:39 PM		Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
4:49 PM		LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
4:55 PM		PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
7:01 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
5:14 PM		Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
5:18 PM		Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
4:48 PM		Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
8:19 AM		PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
05/10/2023
7:00 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
7:02 AM		PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2023
11:15 PM		PMV Pharmaceuticals (Filer)
Form EFFECT
04/28/2023
7:01 AM		PMV Pharmaceuticals (Filer)
Form DEF 14A
04/28/2023
7:01 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
7:03 AM		PMV Pharmaceuticals (Filer)
Form DEFA14A
04/28/2023
7:04 AM		PMV Pharmaceuticals (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:PMVP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends